Connecting Chinese pharmaceutical technology with Iranian engineering, manufacturing and lifecycle support — to modernize the Iranian pharmaceutical industry.
CinoPersa is a trademark-registered China–Iran joint venture established by Mr. Hosseini (CEO, Parseh Industrial Group) and Mr. Miachel (CEO, Newbow) under a shared vision for the Iranian pharmaceutical industry.
Iranian pharmaceutical manufacturers face simultaneous pressure from localized regulatory and supply isolation, alongside an urgent need for production modernization. Access to high-end technology — injectables, OSD, lyophilization and biotech — must not inflate end-user costs.
The strategic gap. Global OEMs cannot reliably serve the Iranian market due to compliance and payment barriers; local manufacturers lack a single, trusted gateway for technology transfer, engineering and long-term lifecycle support.
The CinoPersa answer. One accountable partner combining Chinese technology leadership with Iranian manufacturing heritage.
The CinoPersa name carries both sides of the partnership — and the logo weaves them into one continuous, precise mark.
China's advanced pharmaceutical machinery manufacturing, technology pipelines and global supply chain. The "Cino" prefix signals precision, scale and technological leadership.
Honors Iran's ancient Persian heritage, Parseh Industrial Group and the nation's deep pharmaceutical tradition — local expertise, cultural identity and long-term commitment.

Traditional knots represent continuity, harmony and interconnectedness — a visual metaphor for systems that remain linked, stable and uninterrupted.

Structure and precision aligned with the engineering mindset — circular geometry and continuous rhythm echoing classical Islamic patterns in a contemporary technical symbol.
Two complementary organizations, one shared vision for Iranian pharma modernization.
One shared direction, five principles — the foundation of every project we deliver.
To establish Iran as the premier regional pharmaceutical manufacturing and technology hub — elevating the international influence and competitiveness of the Iranian pharmaceutical ecosystem through technology, local manufacturing and global market access.
Empower Iranian producers with high-end technology and global market access — delivering comprehensive engineering services, local manufacturing and sanction-proof supply chains to facilitate the modernization of the Iranian pharmaceutical industry.
World-class engineering quality in everything we deliver.
Transparent, compliant operations at every step.
A win-win partnership mindset with every customer.
Continuous technology advancement for the industry.
Long-term dedication to Iran and its pharma future.